Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 86 results found. Search for [ new drug pricing policy ]

Results 1 to 21 of 86
PB Jayakumar
May 3, 2021
Demand fell to almost nil by January after the first wave of the pandemic in the country. Since there was no demand, most manufacturers stopped giving fresh orders for manufacturing


Aprajita Sharma
April 23, 2021
The insurance companies are swamped with COVID-19 claims. Even if your policy is eligible for cashless settlement, they are not offering it


Joe C Mathew and Nidhi Singal
New Delhi, April 14, 2021
The Production Linked Incentive Scheme aims to build an Indian manufacturing base across 13 key sectors. What works. What doesn't


BusinessToday.In
March 20, 2021
NPPA, with this price regulation, has re-assured the availability of medicines at fair prices to the public


PB Jayakumar
February 25, 2021
To reach that target from the current $42 billion, the Indian pharmaceutical industry will require to double the last decade's growth rate of 6% to 12%


BusinessToday.In
February 11, 2021
Stock Market News Updates Today: RIL, Bajaj twins, Airtel were among the top gainers while, Nestle, TCS, Axis Bank, L&T traded as the top losers


BusinessToday.In
February 10, 2021
Stock Market News Updates Today: Tata Motors, L&T , Infosys, Airtel, SBI, ONGC, ITC, Nestle were among the top losers today while HUL, Titan, M&M, TCS, Bajaj Finance, HDFC traded among the top gainers.


Associated Press
July 20, 2020
For months before studies like these, learning what helps or harms has been undermined by \"desperation science\" as doctors and patients tried therapies on their own or through a host of studies not strong enough to give clear answers


BusinessToday.In
June 30, 2020
In the US, federal health officials have allocated the limited supply to states, but that agreement with Gilead will end after September


Joe C Mathew | PB Jayakumar
March 4, 2020
'Right now, the focus is  about 80% innovative medicines and 20 per cent generics. We have 15 launches coming up in innovative medicines,' Novartis International CEO said


Joe C Mathew and PB Jayakumar
March 3, 2020
Novartis has completed strategic transactions worth over $70 billion since he took charge as CEO in 2018. In an exclusive interview with Business Today's Joe C. Mathew and P.B. Jayakumar, the second generation Indian American speaks about his vision for Novartis, new launches in India and the growing role of its Hyderabad centre


E Kumar Sharma
New Delhi, December 31, 2019
Most in the Indian pharma industry are hopeful that the new National List of Essential Medicines (NLEM) expected in 2020 will not be too disruptive


PTI
May 24, 2019



BusinessToday.In
New Delhi, May 17, 2019
In March, the rates were brought down for around 380 drugs, with some cuts going to as much as 80-90 per cent under trade margin rationalisation.


PTI
April 1, 2019



K.T.P. Radhika
New Delhi, February 5, 2019
With global giants Amazon and Netflix pouring money to develop original Indian content and desi players not far behind, the OTT race has entered an exciting phase.


PTI
January 27, 2019



PTI
January 23, 2019



E Kumar Sharma
January 18, 2019
Globally, the number of diabetes patients is at around half a billion with over 30 million in the US alone, the most sought after market for diabetes care companies, especially those into insulin.


PTI
December 21, 2018



PAGES 1 OF 5  12345